Cannell & Co. Abb Vie Inc. Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cannell & Co. holds 230,806 shares of ABBV stock, worth $39.6 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

230,806

Previous 226,746 1.79%

Holding current value

$39.6 Million

Previous $33.8 Million 5.83%

% of portfolio

1.19%

Previous 1.19%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $558,656 - $629,178	4,060 Added 1.79%	230,806 $35.8 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $530,352 - $613,960	-3,970 Reduced 1.72%	226,746 $33.8 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $630,747 - $784,924	-4,760 Reduced 2.02%	230,716 $31.1 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $1.56 Million - $1.79 Million	-10,756 Reduced 4.37%	235,476 $37.5 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $6,362 - $7,630	-46 Reduced 0.02%	246,232 $39.8 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $207,891 - $238,437	-1,549 Reduced 0.63%	246,278 $33.1 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $2.82 Million - $3.58 Million	-20,477 Reduced 7.63%	247,827 $38 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $2.15 Million - $2.66 Million	-16,273 Reduced 5.72%	268,304 $43.5 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $697,757 - $882,865	-6,495 Reduced 2.23%	284,577 $38.5 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $13.9 Million - $15.8 Million	-130,781 Reduced 31.0%	291,072 $31.4 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $11.3 Million - $12.6 Million	-107,859 Reduced 20.36%	421,853 $47.5 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $875,074 - $963,351	-8,554 Reduced 1.59%	529,712 $57.3 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $150,516 - $203,212	1,870 Added 0.35%	538,266 $57.7 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $996,384 - $1.17 Million	11,598 Added 2.21%	536,396 $47 Million
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $12.6 Million - $16.9 Million	-171,866 Reduced 24.67%	524,798 $51.5 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $4.37 Million - $6.62 Million	-67,709 Reduced 8.86%	696,664 $53.1 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $16.3 Million - $20.4 Million	226,421 Added 42.09%	764,373 $67.7 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $2.69 Million - $3.24 Million	-42,741 Reduced 7.36%	537,952 $40.7 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $11.7 Million - $14.9 Million	177,924 Added 44.18%	580,693 $42.2 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $424,501 - $499,617	5,503 Added 1.39%	402,769 $32.5 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $3.61 Million - $4.45 Million	-46,340 Reduced 10.45%	397,266 $36.6 Million
Q3 2018 Nov 05, 2018	BUY	$88.91 - $98.84 $4.05 Million - $4.51 Million	45,579 Added 11.45%	443,606 $42 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $9.4 Million - $11.1 Million	-104,701 Reduced 20.83%	398,027 $36.9 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $1.18 Million - $1.58 Million	-12,852 Reduced 2.49%	502,728 $47.6 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $427,828 - $469,149	-4,777 Reduced 0.92%	515,580 $49.9 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $36.3 Million - $46.4 Million	520,357	520,357 $46.2 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account